Skip to main content
Erschienen in: Clinical Oral Investigations 2/2015

01.03.2015 | Original Article

Relation of gelsolin amyloidosis and periodontal health

verfasst von: Pirjo L. Juusela, Rutger G. Persson, Anja R. Nieminen, Sari M. Kiuru-Enari, Veli-Jukka Uitto

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

Hereditary gelsolin amyloidosis (AGel amyloidosis) is a rare, dominantly inherited systemic disease with worldwide distribution, caused by a gelsolin gene mutation. We studied the periodontal conditions and microbiological plaque composition of AGel amyloidosis patients.

Material and methods

A voluntary study group of 36 AGel amyloidosis patients (mean age 61) filled in a questionnaire. A thorough periodontal examination included periodontal pocket depth and attachment level measurements, registrations of visible plaque, bleeding on probing and panoramic radiographs. The presence of oral Candida was studied by fungal culture method. Bacterial samples from deepened pockets (≥4 mm) were analyzed with checkerboard DNA-DNA hybridization method.

Results

VPI (15.3 %) and BOP (11.2 %) of the patients were modest reflecting relatively adequate oral self-care. Still 89 % of the patients had at least one PPD of ≥4 mm; 78.5 % of the PPDs ≥6 mm were found in molars. Patients had lost one third of the molars due to periodontitis and/or tooth decay. Half of the patients (53 %) were Candida carriers. Bacterial analysis of subgingival plaque samples revealed bacterial species common to chronic periodontitis.

Conclusion

AGel amyloidosis may increase the risk for periodontitis even when the oral self-care is adequate. Molar teeth appear to be mostly affected, leading to tooth loss.

Clinical relevance

AGel amyloidosis as a systemic disease is related with a vast variety of symptoms with variable severity. Even though a causal relationship of the systemic disease and periodontitis has not yet been proven, increased risk for periodontal problems should be considered when examining AGel amyloidosis patients.
Literatur
1.
Zurück zum Zitat Berezow AB, Darveau RP (2011) Microbial shift and periodontitis. Periodontol 55:36–47CrossRef Berezow AB, Darveau RP (2011) Microbial shift and periodontitis. Periodontol 55:36–47CrossRef
2.
Zurück zum Zitat Stabholz A, Soskolne WA, Shapira L (2010) Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis. Periodontol 53:138–153CrossRef Stabholz A, Soskolne WA, Shapira L (2010) Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis. Periodontol 53:138–153CrossRef
3.
Zurück zum Zitat Meretoja J (1969) Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1:314–324PubMed Meretoja J (1969) Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1:314–324PubMed
4.
Zurück zum Zitat Kiuru-Enari S, Haltia M (2013) Hereditary gelsolin amyloidosis. Handb Clin Neurol 115:659–681CrossRefPubMed Kiuru-Enari S, Haltia M (2013) Hereditary gelsolin amyloidosis. Handb Clin Neurol 115:659–681CrossRefPubMed
5.
Zurück zum Zitat Juusela P, Tanskanen M, Nieminen A, Kari K, Suominen L, Uitto VJ, Kiuru-Enari S (2013) Xerostomia in hereditary gelsolin amyloidosis. Amyloid 20:39–44CrossRefPubMed Juusela P, Tanskanen M, Nieminen A, Kari K, Suominen L, Uitto VJ, Kiuru-Enari S (2013) Xerostomia in hereditary gelsolin amyloidosis. Amyloid 20:39–44CrossRefPubMed
6.
Zurück zum Zitat Paunio T, Kiuru S, Hongell V, Mustonen E, Syvanen AC, Bengstrom M, Palo J, Peltonen L (1992) Solid-phase minisequencing test reveals Asp187––Asn (G654––A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 13:237–239CrossRefPubMed Paunio T, Kiuru S, Hongell V, Mustonen E, Syvanen AC, Bengstrom M, Palo J, Peltonen L (1992) Solid-phase minisequencing test reveals Asp187––Asn (G654––A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 13:237–239CrossRefPubMed
7.
Zurück zum Zitat Meurman JH, Parnanen P, Kari K, Samaranayake L (2009) Effect of amine fluoride-stannous fluoride preparations on oral yeasts in the elderly: a randomised placebo-controlled trial. Gerodontology 26:202–209CrossRefPubMed Meurman JH, Parnanen P, Kari K, Samaranayake L (2009) Effect of amine fluoride-stannous fluoride preparations on oral yeasts in the elderly: a randomised placebo-controlled trial. Gerodontology 26:202–209CrossRefPubMed
8.
Zurück zum Zitat Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE (1994) “Checkerboard”DNA-DNA hybridization. Bio Tech 17:788–792 Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE (1994) “Checkerboard”DNA-DNA hybridization. Bio Tech 17:788–792
9.
Zurück zum Zitat Socransky SS, Haffajee AD, Smith C, Martin L, Haffajee JA, Uzel NG, Goodson JM (2004) Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol 19:352–362CrossRefPubMed Socransky SS, Haffajee AD, Smith C, Martin L, Haffajee JA, Uzel NG, Goodson JM (2004) Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol 19:352–362CrossRefPubMed
10.
Zurück zum Zitat Katsoulis J, Heitz-Mayfield LJ, Weibel M, Hirschi R, Lang NP, Persson GR (2005) Impact of sample storage on detection of periodontal bacteria. Oral Microbiol Immunol 20:128–130CrossRefPubMed Katsoulis J, Heitz-Mayfield LJ, Weibel M, Hirschi R, Lang NP, Persson GR (2005) Impact of sample storage on detection of periodontal bacteria. Oral Microbiol Immunol 20:128–130CrossRefPubMed
11.
Zurück zum Zitat Sethi SK, Bunchman T, Raina R, Kher V (2013) Unique considerations in renal replacement therapy in children: core curriculum 2014. Am J Kidney Dis Sethi SK, Bunchman T, Raina R, Kher V (2013) Unique considerations in renal replacement therapy in children: core curriculum 2014. Am J Kidney Dis
12.
Zurück zum Zitat Haltia M, Ghiso J, Prelli F, Gallo G, Kiuru S, Somer H, Palo J, Frangione B (1990) Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 136:1223–1228PubMedCentralPubMed Haltia M, Ghiso J, Prelli F, Gallo G, Kiuru S, Somer H, Palo J, Frangione B (1990) Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 136:1223–1228PubMedCentralPubMed
13.
Zurück zum Zitat Maury CP (1991) Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 64:400–404PubMed Maury CP (1991) Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 64:400–404PubMed
14.
Zurück zum Zitat Solomon JP, Page LJ, Balch WE, Kelly JW (2012) Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol 47:282–296CrossRefPubMedCentralPubMed Solomon JP, Page LJ, Balch WE, Kelly JW (2012) Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol 47:282–296CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Westberg JA, Zhang KZ, Andersson LC (1999) Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin. FASEB J 13:1621–1626PubMed Westberg JA, Zhang KZ, Andersson LC (1999) Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin. FASEB J 13:1621–1626PubMed
16.
Zurück zum Zitat Kiuru S, Javela K, Somer H, Kekomaki R (2000) Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis. Thromb Haemost 83:491–495PubMed Kiuru S, Javela K, Somer H, Kekomaki R (2000) Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis. Thromb Haemost 83:491–495PubMed
17.
Zurück zum Zitat Li GH, Arora PD, Chen Y, McCulloch CA, Liu P (2012) Multifunctional roles of gelsolin in health and diseases. Med Res Rev 32(5):999–1025CrossRefPubMed Li GH, Arora PD, Chen Y, McCulloch CA, Liu P (2012) Multifunctional roles of gelsolin in health and diseases. Med Res Rev 32(5):999–1025CrossRefPubMed
18.
Zurück zum Zitat Tanskanen M, Paetau A, Salonen O, Salmi T, Lamminen A, Lindsberg P, Somer H, Kiuru-Enari S (2007) Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: a case report. Amyloid 14:89–95CrossRefPubMed Tanskanen M, Paetau A, Salonen O, Salmi T, Lamminen A, Lindsberg P, Somer H, Kiuru-Enari S (2007) Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: a case report. Amyloid 14:89–95CrossRefPubMed
19.
Zurück zum Zitat Pihlamaa T, Rautio J, Kiuru-Enari S, Suominen S (2011) Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg 127:2342–2351CrossRefPubMed Pihlamaa T, Rautio J, Kiuru-Enari S, Suominen S (2011) Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg 127:2342–2351CrossRefPubMed
20.
Zurück zum Zitat Maury CP, Kere J, Tolvanen R, de la Chapelle A (1992) Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13:902–903CrossRefPubMed Maury CP, Kere J, Tolvanen R, de la Chapelle A (1992) Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13:902–903CrossRefPubMed
21.
Zurück zum Zitat Ardalan MR, Shoja MM, Kiuru-Enari S (2007) Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrol Dial Transplant 22:272–275CrossRefPubMed Ardalan MR, Shoja MM, Kiuru-Enari S (2007) Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrol Dial Transplant 22:272–275CrossRefPubMed
22.
Zurück zum Zitat Persson GR, Yeates J, Persson RE, Hirschi-Imfeld R, Weibel M, Kiyak HA (2007) The impact of a low-frequency chlorhexidine rinsing schedule on the subgingival microbiota (the TEETH clinical trial). J Periodontol 78:1751–1758CrossRefPubMed Persson GR, Yeates J, Persson RE, Hirschi-Imfeld R, Weibel M, Kiyak HA (2007) The impact of a low-frequency chlorhexidine rinsing schedule on the subgingival microbiota (the TEETH clinical trial). J Periodontol 78:1751–1758CrossRefPubMed
23.
Zurück zum Zitat Persson GR, Hitti J, Paul K, Hirschi R, Weibel M, Rothen M, Persson RE (2008) Tannerella forsythia and Pseudomonas aeruginosa in subgingival bacterial samples from parous women. J Periodontol 79:508–516CrossRefPubMed Persson GR, Hitti J, Paul K, Hirschi R, Weibel M, Rothen M, Persson RE (2008) Tannerella forsythia and Pseudomonas aeruginosa in subgingival bacterial samples from parous women. J Periodontol 79:508–516CrossRefPubMed
24.
Zurück zum Zitat Agerbaek MR, Lang NP, Persson GR (2006) Microbiological composition associated with interleukin-1 gene polymorphism in subjects undergoing supportive periodontal therapy. J Periodontol 77:1397–1402CrossRefPubMed Agerbaek MR, Lang NP, Persson GR (2006) Microbiological composition associated with interleukin-1 gene polymorphism in subjects undergoing supportive periodontal therapy. J Periodontol 77:1397–1402CrossRefPubMed
25.
Zurück zum Zitat Benjasupattananan S, Lai CS, Persson GR, Pjetursson BE, Lang NP (2005) Effect of a stannous fluoride dentifrice on the sulcular microbiota: a prospective cohort study in subjects with various levels of periodontal inflammation. Oral Health Prev Dent 3:263–272PubMed Benjasupattananan S, Lai CS, Persson GR, Pjetursson BE, Lang NP (2005) Effect of a stannous fluoride dentifrice on the sulcular microbiota: a prospective cohort study in subjects with various levels of periodontal inflammation. Oral Health Prev Dent 3:263–272PubMed
26.
Zurück zum Zitat Hazenberg BP (2013) Amyloidosis: a clinical overview. Rheum Dis Clin N Am 39:323–345CrossRef Hazenberg BP (2013) Amyloidosis: a clinical overview. Rheum Dis Clin N Am 39:323–345CrossRef
27.
Zurück zum Zitat Cengiz MI, Wang HL, Yildiz L (2010) Oral involvement in a case of AA amyloidosis: a case report. J Med Case Rep 4:200-1947-4-200 Cengiz MI, Wang HL, Yildiz L (2010) Oral involvement in a case of AA amyloidosis: a case report. J Med Case Rep 4:200-1947-4-200
28.
Zurück zum Zitat Nakamura T (2011) Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments. Clin Exp Rheumatol 29:850–857PubMed Nakamura T (2011) Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments. Clin Exp Rheumatol 29:850–857PubMed
29.
Zurück zum Zitat Basturk T, Ozagari A, Ozturk T, Kusaslan R, Unsal A (2009) Crohn’s disease and secondary amyloidosis: early complication? A case report and review of the literature. J Ren Care 35:147–150CrossRefPubMed Basturk T, Ozagari A, Ozturk T, Kusaslan R, Unsal A (2009) Crohn’s disease and secondary amyloidosis: early complication? A case report and review of the literature. J Ren Care 35:147–150CrossRefPubMed
30.
Zurück zum Zitat Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, Ataman R, Akpolat T, Ok E, Sen S, Dusunsel R, Evrenkaya R, Akoglu E (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17:2003–2005CrossRefPubMed Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, Ataman R, Akpolat T, Ok E, Sen S, Dusunsel R, Evrenkaya R, Akoglu E (2002) A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17:2003–2005CrossRefPubMed
31.
Zurück zum Zitat Amir AR, Sheikh SS (2006) Hodgkin's lymphoma with concurrent systemic amyloidosis, presenting as acute renal failure, following lymphomatoid papulosis. J Nephrol 19:361–365PubMed Amir AR, Sheikh SS (2006) Hodgkin's lymphoma with concurrent systemic amyloidosis, presenting as acute renal failure, following lymphomatoid papulosis. J Nephrol 19:361–365PubMed
32.
Zurück zum Zitat Nobata H, Suga N, Itoh A, Miura N, Kitagawa W, Morita H, Yokoi T, Banno S, Imai H (2012) Systemic AA amyloidosis in a patient with lung metastasis from renal cell carcinoma. Amyloid 19:197–200CrossRefPubMed Nobata H, Suga N, Itoh A, Miura N, Kitagawa W, Morita H, Yokoi T, Banno S, Imai H (2012) Systemic AA amyloidosis in a patient with lung metastasis from renal cell carcinoma. Amyloid 19:197–200CrossRefPubMed
33.
Zurück zum Zitat Stridsberg M, Wilander E (1991) Islet amyloid polypeptide (IAPP). A short review. Acta Oncol 30:451–456CrossRefPubMed Stridsberg M, Wilander E (1991) Islet amyloid polypeptide (IAPP). A short review. Acta Oncol 30:451–456CrossRefPubMed
34.
Zurück zum Zitat Rocken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111–122CrossRefPubMed Rocken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111–122CrossRefPubMed
35.
Zurück zum Zitat Cengiz MI, Bagci H, Cengiz S, Yigit S, Cengiz K (2009) Periodontal disease in patients with familial Mediterranean fever: from inflammation to amyloidosis. J Periodontal Res 44:354–361CrossRefPubMed Cengiz MI, Bagci H, Cengiz S, Yigit S, Cengiz K (2009) Periodontal disease in patients with familial Mediterranean fever: from inflammation to amyloidosis. J Periodontal Res 44:354–361CrossRefPubMed
36.
Zurück zum Zitat Paunio T, Kiuru S, Karonen S, Palo J, Peltonen L (1994) Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid Int J Exp Clin Invest 1:80–89 Paunio T, Kiuru S, Karonen S, Palo J, Peltonen L (1994) Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid Int J Exp Clin Invest 1:80–89
Metadaten
Titel
Relation of gelsolin amyloidosis and periodontal health
verfasst von
Pirjo L. Juusela
Rutger G. Persson
Anja R. Nieminen
Sari M. Kiuru-Enari
Veli-Jukka Uitto
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 2/2015
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-014-1254-x

Weitere Artikel der Ausgabe 2/2015

Clinical Oral Investigations 2/2015 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.